Arsenale Bioyards has secured funding to enhance its AI-driven biomanufacturing system, aiming to revolutionise the industry by significantly reducing production costs and making eco-friendly products more affordable.
Arsenale Bioyards, a neo-industrial company transforming biomanufacturing, has raised $10M in funding to enhance its AI-driven system, which aims to reduce production costs by up to 90%.
The investment round was led by Planet A and byFounders, with additional backing from CDP Ventures, Acequia Capital, Plug N Play, Grey Silo Ventures, and other investors including industrial family offices.
Arsenale Bioyards costs saving for sustainable biomanufacturing
Imagine a world where eco-friendly products are just as affordable as conventional ones. Arsenale Bioyards is making this vision a reality by revolutionising the $200B biomanufacturing industry. Its proprietary platform integrates cutting-edge software with advanced bioreactors to speed up production while significantly lowering costs.
How Arsenale Bioyards is harnessing nature’s power for better production
Inspired by natural processes, Arsenale Bioyards uses precision fermentation, a method that employs microorganisms like yeast or bacteria to create valuable products. While this technique is widely used in pharmaceuticals, its high cost has limited its application in industries such as food and cosmetics. Arsenale’s groundbreaking end-to-end system is designed to make precision fermentation far more cost-effective—cutting expenses by up to 90%—which will accelerate the adoption of sustainable alternatives.
The company’s Bioyards system features modular industrial bioreactors that enable businesses to scale production efficiently and affordably compared to conventional methods.
“At Planet A, we saw Arsenale’s potential early on—this is a fundamental rethink of how biomanufacturing scales. By making production cost-competitive and standardised, Arsenale turns biomanufacturing into an investable asset class while enabling industries to move away from animal- and petrochemical-derived products at scale,” said Christoph Gras, Co-Founder & General Partner at Planet A Ventures.
Data-driven innovation for better efficiency
Arsenale’s platform leverages real-time data to optimise production, reducing inefficiencies and improving performance. By designing its own bioreactors, the company ensures seamless integration with AI-driven models, helping businesses accelerate production while maintaining high quality and minimising costs.
“Arsenale is not only imagining the bioeconomy of the future—we are building it today, with operational facilities and proprietary technology,” said Massimo Portincaso, CEO and Co-Founder of Arsenale Bioyards. “This funding reinforces our ability to drive measurable change and underscores our aspiration to build a new generative, biology-driven industrial paradigm.”
A powerhouse team of industry experts
Arsenale Bioyards was founded by a team of experts from diverse fields including engineering, biotechnology, artificial intelligence, and large-scale manufacturing. Leading the team is Massimo Portincaso, the CEO and Co-Founder, who has a proven record as a business consultant and entrepreneur in launching and scaling biotech companies.
Dr. Gordana Djordjevic, the Chief Scientific Officer, brings over 25 years of experience as a fermentation expert from prominent companies like Perfect Day, Zymergen, and BASF.
Niels Lynge Agerbæk, the Chief Technical Officer, specialises in technical solutions for large-scale production, with experience from Zymergen and Novo Nordisk.
Dr. Matteo Zanotto, the Chief Information Officer, holds a PhD in deep learning and AI, and is responsible for driving software innovation at Arsenale Bioyards.
Rounding out the team is Arnaud Legris, the Chief Operating Officer, an engineer and former consultant who oversees daily operations.
What’s next for Arsenale Bioyards?
With its newly secured $10M funding, Arsenale Bioyards plans to expand its facilities, introduce its technology to industries such as food and cosmetics, and further solidify its role in sustainable manufacturing.
The company already operates a pilot site in Pordenone, Italy, equipped with 1,000-litre precision fermentation capacity, including advanced bioreactors. This infrastructure positions Arsenale Bioyards to support industries in transitioning to eco-friendly, cost-effective biomanufacturing solutions.
By merging AI-powered technology, state-of-the-art bioreactors, and precision fermentation, Arsenale Bioyards is redefining biomanufacturing, making sustainable production more efficient, accessible, and affordable.
The post Arsenale Bioyards secures $10M to revolutionise biomanufacturing appeared first on Tech Funding News.